In 2025, China's insurance sector is witnessing a surge in capital replenishment. By December, around 20 insurers have disclosed capital increase plans via industry associations, with 12 already approved. These firms aim to raise funds through supplementary capital bonds or perpetual bonds.
With the transitional period for the "Solvency Regulatory Rules for Insurance Companies (Phase II)" extended to end-2025 approaching, stricter solvency adequacy ratio requirements—particularly for core solvency—are pressuring some insurers to meet standards. The implementation of new accounting standards (IFRS17) and persistently low market interest rates further challenge profitability and internal capital accumulation, exacerbating capital strain.
Amid these intersecting factors, insurers are prioritizing capital injections via equity expansions or debt instruments to enhance risk resilience ahead of the solvency "stress test."
1. Industry-Wide Capital Surge: Dual Drivers of Regulation and Market Over 20 insurers have announced or secured approvals for capital boosts in 2025. Notable approvals include China Post Life, Taikang Pension, and Ping An Life, which unveiled a record RMB20 billion plan in April. Between November and December alone, five firms—including Taiping Pension (RMB330 million) and Huatai Property & Casualty (minimum RMB1 billion)—initiated fundraising.
The trend reflects "large-scale, concentrated" moves, driven by IFRS17's conservative liability measurements and low-yield investment environments squeezing internal capital growth. Experts cite dual motivations: meeting growth-driven capital demands and refinancing high-cost debt.
Regulatory tightening post-Phase II solvency reforms—raising the core solvency floor to 50%—alongside enhanced risk ratings (IRR) and capital planning assessments, is compelling external fundraising.
2. Firm-Level Dynamics: Three Key Motivations Capital replenishment motives fall into three categories: - **Growth Capital**: Startups like Hengqin Life, despite adequate solvency ratios (189% comprehensive; 157% core in mid-2025), seek buffers for expanding premium volumes and future claims. - **Equity Optimization**: Huatai P&C, burdened by shareholder constraints (60.42% held by troubled HNA affiliates), aims to attract new investors via a RMB1 billion+ equity sale while addressing past "C"-rated risk management gaps. - **Strategic Expansion**: Pacific Insurance is injecting up to HKD4.5 billion into its Hong Kong subsidiaries to support regional growth.
3. Solvency Remains the North Star While specifics vary, solvency enhancement underpins all cases. Stricter regulations and operational complexities—from claims-cost volatility to auto-insurance reforms—make capital boosts critical for compliance and competitiveness.
The 2025 wave also highlights foreign and state-backed investors' confidence, bringing capital and expertise. However, translating funds into operational efficiency and strategic agility will separate future leaders from laggards in an increasingly polarized market.